Chronische myeloproliferatieve neoplasma’s

Barrett J. Allogeneic stem cell transplantation for chronic myeloid leukemia. Semin Hematol 2003;40:59-71.

Druker BJ, Guilhot F, O’Brien SG, et al.; IRIS Investigators. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006;355:2408-17.

Santos FP, Verstovsek S. Therapy with JAK2 Inhibitors for myeloproliferative neoplasms. Hematol Oncol Clin North Am. 2012;26:1083-99.

Wadleigh M, Teff eri A. Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World

Health Organization criteria. Int J Hematol. 2010;91:174-9.